Apeiron Investment Group Ltd. - Jul 1, 2024 Form 3 Insider Report for BIONOMICS LTD/ADR (BNOX)

Role
10%+ Owner
Signature
Apeiron Investment Group Ltd. By: /s/ Mario Frendo, Director
Stock symbol
BNOX
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
3
Date filed
10/7/2024, 06:17 PM
Previous filing
Apr 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BNOX Ordinary Shares 183M Jul 1, 2024 By Apeiron Investment Group Ltd. F1, F2
holding BNOX Ordinary Shares 93.4M Jul 1, 2024 By Apeiron Presight Capital Fund II, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes Ordinary Shares represented by American Depositary Shares.
F2 The reportable securities are held by Apeiron Investment Group Ltd. ("Apeiron"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities.
F3 The reportable securities are held by Apeiron Presight Capital Fund II, L.P. ("Apeiron Presight"). Apeiron and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. ("Presight Management"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities.

Remarks:

The Reporting Persons were unaware that the Issuer ceased to be a foreign private issuer as of July 1, 2024, resulting in this delinquent report on Form 3.